Scleral contact lenses Market Size, Production, Sales, Average Product Price, Market Share, Import vs Export

Scleral contact lenses Market: Evolving design and clinical adoption

The Scleral contact lenses market is shifting from a niche therapeutic solution to a mainstream option for patients with complex corneal disorders and severe dry‑eye disease. Unlike traditional rigid gas‑permeable or soft lenses, modern scleral contact lenses rest on the sclera while vaulting over the irregular or damaged cornea, creating a stable optical interface and a tear reservoir that protects the ocular surface. This design advantage has translated into a measurable uptick in clinical prescriptions, especially in specialty eye‑care centers and refractive‑surgery follow‑up clinics. As a result, the Scleral contact lenses market is increasingly perceived as a core component of advanced visual‑rehabilitation protocols rather than a last‑resort device.

Rising global prevalence of corneal diseases fuels Scleral contact lenses Market

Globally, corneal ectasia, keratoconus, pellucid marginal degeneration, and post‑surgical irregular astigmatism are affecting tens of millions of individuals, with prevalence estimates for keratoconus alone ranging from 1 in 2,000 to 1 in 450 in different populations. In such patients, conventional contact lenses often fail to provide stable vision or comfort, whereas scleral contact lenses can correct irregular optics and reduce glare. For example, in North America and Western Europe, scleral designs now account for a growing share of contact‑lens fittings in corneal‑ectasia clinics, with reported success rates exceeding 80–90% in specialized centers. This clinical reliability is directly reflected in the Scleral contact lenses market, as eye‑care providers increasingly adopt these lenses as a first‑line optical correction strategy for irregular corneas.

Scleral contact lenses Market driven by expanding dry‑eye and ocular‑surface disease pool

Dry‑eye disease and other ocular‑surface disorders are another major driver of the Scleral contact lenses market. Studies suggest that between 5% and 30% of adults worldwide experience moderate to severe dry‑eye symptoms, depending on geography and age band. In these patients, traditional contact lenses frequently exacerbate discomfort, while scleral contact lenses maintain a continuous saline‑like environment between the lens and the cornea, effectively shielding the ocular surface. Specialty clinics treating Sjögren’s syndrome, graft‑versus‑host disease, and chronic blepharitis, for instance, report a marked drop in dropout rates when patients are switched from soft lenses to scleral designs. This shift is not anecdotal; internal practice‑level data from large‑scale eye‑care networks show prescription volumes of scleral lenses for dry‑eye indications rising at mid‑teens year‑on‑year in some regions, reinforcing the Scleral contact lenses market’s structural growth backdrop.

Technological enhancements strengthening the Scleral contact lenses Market value proposition

Material innovations, design optimization, and digital‑fitting workflows are collectively upgrading the Scleral contact lenses market’s value proposition. High‑Dk (oxygen‑permeable) materials now allow for thicker lenses without compromising corneal oxygenation, enabling longer wearing times and improved safety. Customized designs, including aspheric optics, variable base‑curve profiles, and landing‑zone modifications, have reduced lens flexure and edge‑bearing issues that previously limited comfort and vision. For example, manufacturers have introduced designs with posterior asphericity and rotational‑stabilization features that cut induced higher‑order aberrations by up to 30–40% in some clinical cohorts. These improvements translate into fewer follow‑up visits and higher patient satisfaction, which in turn strengthens the business case for eye‑care practices to participate more actively in the Scleral contact lenses market.

Digital eye‑mapping and practice integration accelerating Scleral contact lenses Market penetration

The integration of corneal topography, anterior‑segment OCT, and wavefront aberrometry into routine practice has dramatically reduced the barrier to fitting scleral contact lenses. Instead of relying on trial‑and‑error lens sets, clinicians can now model lens‑cornea clearance and predict optimal base‑curve ranges before a single lens touches the eye. Practices equipped with digital fitting‑guidance software report that the average time to achieve a stable, comfortable scleral fit has shrunk by nearly 30–50% compared with conventional methods. In large optical‑retail chains and multi‑specialty clinics, this efficiency gain has turned scleral contact lenses fitting into a commercially viable service line, not just a time‑consuming specialty procedure. As a result, the Scleral contact lenses market is seeing a steady migration from university‑hospital‑centric adoption to private‑practice and optical‑chain‑driven uptake.

Scleral contact lenses Market expanding into post‑surgical and refractive indications

Beyond corneal ectasia and dry‑eye, the Scleral contact lenses market is gaining traction in post‑surgical and refractive‑enhancement scenarios. Patients recovering from penetrating keratoplasty, deep‑anterior lamellar keratoplasty, or refractive‑surgery complications often present with irregular corneas and fluctuating vision; scleral lenses offer a stable optical platform that can restore functional vision without the need for invasive revision surgery. In some refractive‑surgery centers, post‑LASIK or post‑SMILE patients with persistent higher‑order aberrations or irregular astigmatism are now being offered custom scleral lenses as a non‑surgical enhancement option. For instance, limited‑scale data from refractive‑surgery institutes indicate that up to 15–20% of presbyopia‑corrected or high‑WD‑myopia patients may benefit from a scleral solution in certain light‑management or night‑vision scenarios. This diversification of use‑cases is broadening the Scleral contact lenses market’s addressable patient base beyond the classic “difficult‑fit” cohort.

Aging population and rising vision‑quality expectations supporting Scleral contact lenses Market

Demographic aging and rising patient expectations for high‑quality vision are additional structural tailwinds for the Scleral contact lenses market. As global populations age, the incidence of cataract, macular degeneration, and other age‑related ocular conditions increases, but so does the prevalence of multifocal and toric intraocular‑lens implants that can induce residual higher‑order aberrations. In such cases, pairing premium IOLs with scleral contact lenses as a fine‑tuning step can sharpen visual acuity and contrast sensitivity, particularly in low‑light environments. Cataract‑surgery centers in Europe and North America have begun incorporating scleral contact lenses fitting into their “premium‑vision” pathways, reporting that patients with residual irregular astigmatism after toric‑IOL implantation show 20–30% better contrast‑sensitivity scores when wearing a customized scleral lens. These clinically demonstrable outcomes are helping to justify the higher price point associated with the Scleral contact lenses market in value‑based care models.

Scleral contact lenses Market Size and regional growth differentiation

The Scleral contact lenses market size is still modest compared with the broader contact‑lens industry, but it is expanding at a significantly higher rate. In North America and Western Europe, where specialty eye‑care infrastructure is well developed, the Scleral contact lenses market size is estimated to be several times larger than in emerging regions, with annual growth rates in the high‑single to low‑teens range. Conversely, in Asia‑Pacific and Latin America, the Scleral contact lenses market is starting from a smaller base but is posting double‑digit growth, driven by rising medical‑tourism hubs, expanding private‑health coverage, and the establishment of regional cornea‑and‑contact‑lens centers. For example, in countries such as India and Brazil, the number of scleral contact lenses fittings per year has increased by roughly 20–25% over the past three to four years, reflecting both improved clinical awareness and growing patient willingness to invest in vision‑quality improvements.

Premium pricing and reimbursement trends shaping the Scleral contact lenses Market

Pricing and reimbursement remain key enablers for the Scleral contact lenses market. Custom scleral lenses typically carry a price tag that is several times higher than standard soft lenses, reflecting material costs, design complexity, and the time‑intensive fitting process. However, eye‑care providers are increasingly bundling scleral contact lenses into structured “corneal‑rehabilitation” or “dry‑eye management” packages, which can be partially reimbursed under certain insurance schemes or private‑care plans. In the United States, for example, an increasing number of scleral contact lenses fittings are being coded under specialized contact‑lens fitting and management codes, with some payers recognizing the medical‑necessity aspect for severe dry‑eye and post‑surgical irregular astigmatism. This gradually improving reimbursement environment is reducing the out‑of‑pocket burden on patients and, in turn, expanding the Scleral contact lenses market’s commercial viability beyond the purely elective segment.

Scleral contact lenses Market influenced by direct‑to‑patient and online awareness

The Scleral contact lenses market is also being reshaped by digital‑health and patient‑education channels. Online forums, social‑media groups, and tele‑optometry platforms have made it easier for patients with keratoconus, severe dry‑eye, or post‑surgical visual complaints to discover scleral contact lenses as a viable option. In some markets, more than 40% of scleral contact lenses candidates report having researched the modality online before visiting a clinic, often citing visual examples, patient testimonials, and comparison videos. This pre‑clinic awareness shortens the education‑to‑prescription cycle and allows eye‑care professionals to spend more time on fitting and less on basic explanation. As a result, the Scleral contact lenses market is becoming more demand‑pull‑driven, with informed patients actively seeking out practices that can offer scleral solutions.

Emerging competition and innovation sustaining Scleral contact lenses Market dynamism

Finally, the Scleral contact lenses market benefits from a competitive but highly specialized landscape. Major contact‑lens manufacturers and niche scleral‑lens companies are investing in design libraries, fitting software, and practitioner‑training programs, which in turn expand the pool of skilled fitters. For instance, some players have launched proprietary software suites that generate 10–15 custom base‑curve options from a single topography scan, cutting the number of trial lenses needed by half in many cases. This efficiency gain not only improves the economics of scleral fitting but also increases the likelihood that practices will maintain an in‑house scleral contact lenses program rather than outsourcing to specialist centers. As competition intensifies, the Scleral contact lenses market is likely to see further refinements in lens longevity, comfort profiles, and manufacturing turnaround time, all of which will reinforce the long‑term growth trajectory.

“Track Country-wise Scleral contact lenses Production and Demand through our Scleral contact lenses Production Database”

• • • Scleral contact lenses production database for 22+ countries worldwide
    • Scleral contact lenses sales volume for 22+ countries
    • Country-wise Scleral contact lenses production capacity and production plant mapping, production capacity utilization for 20+ manufacturers
    • Scleral contact lenses production plants and production plant capacity analysis for top manufacturers

Scleral contact lenses Market: North America consolidates early‑mover advantage

North America remains the most mature and highest‑value segment of the Scleral contact lenses market, underpinned by a dense network of specialty eye‑care centers, advanced diagnostic infrastructure, and relatively favorable reimbursement for medically indicated contact‑lens fittings. In the United States alone, the annual volume of scleral contact lenses fittings is estimated to be in the hundreds of thousands, growing at approximately 12–15% year‑on‑year over the past five years. This growth is concentrated in regions with high densities of cornea‑and‑refractive‑surgery centers, such as California, New York, and Texas, where scleral lenses are increasingly embedded into post‑keratoplasty and premium IOL‑enhancement pathways. As a result, the Scleral contact lenses price in North America tends to be among the highest globally, typically ranging from the mid‑three‑ to four‑digit levels per fitted pair when bundled with professional services, reflecting the premium placed on customized design and clinical support.

Scleral contact lenses Market expands in Western Europe on medical‑care backbone

Western Europe represents the second‑largest geography for the Scleral contact lenses market, with strong uptake in countries such as Germany, the United Kingdom, France, and the Benelux region. The growth driver here is a combination of robust public‑health infrastructure, high prevalence of keratoconus screening programs, and increasing integration of scleral contact lenses into hospital‑based corneal‑disease units. In several European cornea‑centers, the share of scleral contact lenses in irregular‑cornea fittings has risen from roughly 30–40% a decade ago to over 60–70% today, driven by better outcomes in visual performance and patient comfort. Scleral contact lenses price levels in Western Europe are generally lower than in North America but still sit at a premium over standard contact lenses, with many clinics adopting bundled tariffs that include topography, trial‑lens sets, and follow‑up visits. This pricing environment supports sustained investment in fitting expertise and digital‑eye‑mapping tools, reinforcing the Scleral contact lenses market’s clinical and commercial depth in the region.

Scleral contact lenses Market accelerates in Asia‑Pacific through rising awareness and medical tourism

Asia‑Pacific is emerging as a high‑growth frontier for the Scleral contact lenses market, led by India, China, South Korea, and select Southeast Asian countries. In India, for example, the annual number of scleral contact lenses fittings has increased at a mid‑to‑high‑teens rate over the last three to four years, fueled by expanding private‑eye‑care chains, corneal‑ectasia screening initiatives, and the rise of medical‑tourism hubs that handle complex refractive and corneal cases. Major metropolitan centers such as Mumbai, Delhi, and Bangalore now host dedicated scleral‑lens clinics where patients travel from tier‑2 and tier‑3 cities for bespoke fitting, illustrating the Scleral contact lenses market’s transition from urban‑niche to regional‑service model. Scleral contact lenses price in India and many Asian markets is typically 30–50% lower than equivalent offerings in North America, yet still carries a substantial premium over standard contact lenses, which helps clinics justify the investment in training and equipment. This pricing‑and‑volume sweet spot is enabling the Scleral contact lenses Price Trend in Asia‑Pacific to move upward gradually as brands and retailers standardize higher‑specification designs.

Latin America and Middle East see niche but structurally growing Scleral contact lenses Market

In Latin America and the Middle East, the Scleral contact lenses market operates at a smaller absolute scale but is expanding structurally due to rising disposable incomes, growth of private‑healthcare networks, and increased awareness of advanced contact‑lens solutions. Countries like Brazil, Mexico, Saudi Arabia, and the United Arab Emirates have reported annual growth rates for scleral contact lenses in the high‑single to low‑teens range, with Brazil and Mexico standing out for their large patient bases with keratoconus. In these markets, the Scleral contact lenses price is often set at a discount relative to North America but at a premium versus local soft‑lens pricing, making it attractive for both specialist clinics and premium optical chains. For example, Brazilian keratoconus‑management centers have started to bundle scleral contact lenses with topography and follow‑up packages, which has helped drive annual per‑clinic fitting volumes up by 20–30%. This blend of improving affordability and clinical sophistication is shaping a positive Scleral contact lenses Price Trend in Latin America and the Middle East, even as the addressable base remains far smaller than in developed economies.

Scleral contact lenses Market segmentation by lens type and customization

Within the global Scleral contact lenses market, segmentation is increasingly defined by design complexity and customization level. On one end are semi‑custom or “mini‑scleral” designs that use standardized base‑curve libraries and can be fitted with limited trial‑lens sets, typically priced at the lower end of the Scleral contact lenses Price spectrum. On the other end are fully custom, digitally designed lenses that leverage advanced topography and OCT data to generate unique profiles for each eye, commanding a premium of 30–50% compared with semi‑custom variants. In many developed markets, fully custom lenses now account for 40–50% of all scleral contact lenses fitted, reflecting the growing demand for precision optics in post‑surgical and dry‑eye patients. This segmentation is also evident in distribution channels, with semi‑custom lenses frequently sold through large optical chains and mail‑order contact‑lens retailers, while fully custom designs are generally dispensed through hospital‑linked clinics and specialty cornea centers—an arrangement that reinforces differentiation in the Scleral contact lenses Price and service model.

Scleral contact lenses Market segmented by indication and patient cohort

Clinically, the Scleral contact lenses market is segmented along indication lines, with the largest segments being keratoconus and other corneal ectasias, followed by severe dry‑eye disease and post‑surgical irregular astigmatism. In keratoconus‑management pathways, scleral contact lenses now represent 50–70% of all advanced contact‑lens solutions in leading centers, with the remainder shared between hybrid and rigid‑gas‑permeable lenses. In dry‑eye and ocular‑surface‑disease cohorts, scleral contact lenses are increasingly adopted in moderate‑to‑severe cases where conventional lubricants and punctal plugs fail to provide adequate relief, often in patients with Sjögren’s syndrome or chronic blepharitis. For example, in some European dry‑eye clinics, switching patients from soft lenses to scleral designs has reduced dropout rates by 25–40% and improved vision‑related quality‑of‑life scores by 20–30%. This indication‑based segmentation is tightening the link between clinical outcomes and Scleral contact lenses Price, as payers and patients alike demand transparent value propositions for each patient cohort.

Scleral contact lenses Market production concentrated in North America and Europe

From a manufacturing standpoint, the Scleral contact lenses market is dominated by a relatively small number of specialized players, with the bulk of high‑end production concentrated in North America and Western Europe. These hubs benefit from strong polymer‑science expertise, stringent regulatory oversight, and proximity to key clinical‑research centers, allowing manufacturers to iterate rapidly on material formulations and design parameters. In the United States and Germany, several leading producers have scaled up capacity over the past five years, with estimated annual output in the mid‑six‑figure range across all scleral contact lenses designs, reflecting both rising domestic demand and exports to emerging markets. This concentrated production base also implies that raw‑material cost shifts, regulatory changes, or labor‑cost pressures in these regions can have an outsized impact on the global Scleral contact lenses Price Trend, particularly for custom and high‑Dk designs that require more specialized equipment and skilled craftsmanship.

Scleral contact lenses Market price dynamics and upgrade spends

Over the last five to seven years, the Scleral contact lenses Price has followed an upward trajectory, although the rate of increase has varied by region and design segment. In North America and Western Europe, the average Scleral contact lenses Price for a fully custom pair has risen by roughly 5–8% per year, in line with general medical‑device inflation and the rising cost of professional fitting services. At the same time, semi‑custom and mini‑scleral designs have seen more moderate price increases of 2–4% annually, as manufacturers leverage economies of scale and standardized production lines. In emerging markets such as India and Brazil, initial price levels are lower, but the Scleral contact lenses Price Trend is gradually aligning with developed‑market norms as local clinics adopt higher‑specification lenses and digital‑fitting workflows. This mix of stable‑to‑rising prices and improving clinical outcomes is encouraging patients to view scleral contact lenses as a long‑term vision‑investment, which in turn supports further growth across the Scleral contact lenses Market.

Scleral contact lenses Market evolving distribution and retail channels

Distribution patterns are also shaping the Scleral contact lenses Price and accessibility landscape. In North America and Western Europe, scleral contact lenses are largely dispensed through independent optometrists, hospital‑linked clinics, and large eye‑care groups, where the professional‑fee component can constitute 30–50% of the total Scleral contact lenses Price. In contrast, parts of Asia‑Pacific and Latin America are seeing a growing role for online contact‑lens retailers and tele‑optometry platforms that bundle scleral lenses with remote consultations and home‑delivery services, often at a 10–20% discount compared with in‑clinic pricing. This channel diversification is creating a bifurcated Scleral contact lenses Price Trend: premium pricing in integrated care settings and value‑oriented pricing in digital‑first channels. As the Scleral contact lenses Market matures, the balance between clinical oversight and cost‑efficiency will remain a critical factor in how pricing structures evolve across geographies.

“Scleral contact lenses Manufacturing Database, Scleral contact lenses Manufacturing Capacity”

• • • Scleral contact lenses top manufacturers market share for 23+ manufacturers
    • Top 5 manufacturers and top 10 manufacturers of Scleral contact lenses in North America, Europe, Asia Pacific
    • Production plant capacity by manufacturers and Scleral contact lenses production data for 20+ market players
    • Scleral contact lenses production dashboard, Scleral contact lenses production data in excel format

Scleral contact lenses Market: Leading manufacturers shaping the landscape

The Scleral contact lenses market is increasingly dominated by a handful of specialized and general‑eyes‑care players that combine proprietary material science, digital design platforms, and strong clinical‑support networks. In North America, companies such as Bausch + Lomb, Visionary Optics, ABB Optical Group, Art Optical Contact Lens, and SynergEyes together account for a substantial share of global scleral contact lenses production and sales. In Europe and Asia, firms like Menicon, EssilorLuxottica, and several regional specialty labs complement this core group, creating a geographically diversified yet highly concentrated Scleral contact lenses market structure. This concentration is underpinned by the high barrier to entry in custom scleral design, regulatory complexity, and the need for close collaboration with eye‑care providers.

Scleral contact lenses Market share by major manufacturers

Within the Scleral contact lenses market, the leading manufacturers hold uneven but meaningful shares, with some players specializing in niche segments while others pursue broader commercial footprints. Bausch + Lomb, for example, is widely recognized as one of the largest players in terms of global revenue and brand presence, with its Zenlens series of scleral contact lenses designed for higher‑order‑aberration correction and irregular‑cornea management. Visionary Optics, operating under the Euclid Vision Group umbrella, focuses heavily on custom prosthetic‑scleral and specialty‑kertaconus‑lens designs, giving it a strong position in post‑surgical and severe‑keratoconus niches. ABB Optical Group carves out a distinct space through its DELTA Scleral line, which leverages a “delta‑change” fitting concept that simplifies complex installations and reduces the number of trial lenses required per fitting. Collectively, these and a few other large players likely account for over half of the global Scleral contact lenses market share, with the balance spread across regional specialty labs and smaller innovators.

Bausch + Lomb: Scaling the Scleral contact lenses Market with Zenlens

Bausch + Lomb has positioned its Zenlens platform as a flagship driver of the Scleral contact lenses market, targeting both keratoconus and post‑refractive‑surgery irregular‑astigmatism patients. The Zenlens CHROMA HOA wavefront‑guided scleral contact lenses, launched in May 2025, are designed to reduce halos, glare, and higher‑order aberrations, enabling some patients to improve from 20/30 to 20/20‑level vision in select clinical settings. This technology‑led approach allows Bausch + Lomb to command a premium within the Scleral contact lenses market, differentiating its offerings from standard off‑the‑shelf designs. The company’s integrated ecosystem—combining material innovation, fitting software, and practitioner‑training programs—has helped consolidate its share in North America and parts of Western Europe, where many large cornea centers now prefer Zenlens as a primary scleral‑lens option for complex cases.

Visionary Optics and EyePrint‑style prosthetic solutions in the Scleral contact lenses Market

Visionary Optics, in conjunction with legacy prosthetic‑scleral platforms such as EyePrint Prosthetics, has carved out a premium segment of the Scleral contact lenses market focused on severe ocular‑surface disease and aniridia. These fully customized, eye‑surface‑conforming scleral contact lenses are manufactured using high‑resolution 3D imaging and advanced lathing techniques, enabling exquisite fit on highly irregular or post‑traumatic surfaces. The resulting devices are often priced at the upper end of the Scleral contact lenses price spectrum, reflecting the intensive design and manufacturing process. Despite their niche application, these prosthetic‑style lenses have become a key growth driver for the Scleral contact lenses market, particularly in tertiary‑care centers and ocular‑rehabilitation clinics where patients have exhausted conventional contact‑lens options.

ABB Optical Group and Art Optical Contact Lens: Expanding the Scleral contact lenses Market footprint

ABB Optical Group’s DELTA Scleral line exemplifies how user‑centric design and simplified fitting workflows can expand the Scleral contact lenses market beyond highly specialized centers. By standardizing a fitting “system” that reduces the number of trial lenses and shortens the learning curve for practitioners, ABB Optical has enabled more optometrists and ophthalmologists to offer scleral contact lenses as part of their routine services. Similarly, Art Optical Contact Lens’s Ampleye series, built on Spline Science Technology and HydroLock moisture‑retention concepts, targets keratoconus and severe dry‑eye patients who require both optical correction and ocular‑surface protection. These product lines are priced competitively within the mid‑to‑high‑end segment of the Scleral contact lenses market, supporting incremental share gains in North America and emerging markets where clinics are cautiously scaling their scleral‑lens offerings.

SynergEyes, CooperVision, and the semi‑custom Scleral contact lenses Market segment

SynergEyes and certain divisions of CooperVision have helped broaden the Scleral contact lenses market by focusing on semi‑custom and hybrid‑style scleral designs that balance cost and customization. SynergEyes’ hybrid and mini‑scleral platforms are designed to offer the stability of a scleral lens with the comfort and familiarity of a soft‑lens interface, appealing to patients who might otherwise reject full‑scleral solutions. These products typically carry a lower Scleral contact lenses Price than fully custom designs, which helps drive higher unit volumes through optical chains and regional eye‑care networks. In parallel, CooperVision and other large‑volume contact‑lens manufacturers are exploring entry‑level scleral or mini‑scleral ranges that can be fitted with fewer trial lenses, further democratizing access to the Scleral contact lenses market. Over the last three to five years, this segment has grown at double‑digit rates in several regions, reflecting both improving affordability and rising patient awareness.

Recent industry developments and news in the Scleral contact lenses Market

The Scleral contact lenses market has witnessed several notable developments over the past 12–18 months that reinforce its trajectory toward mainstream adoption. In May 2025, Bausch + Lomb’s launch of Zenlens CHROMA HOA wavefront‑guided scleral contact lenses marked a significant step in integrating advanced optics into everyday practice, targeting higher‑order‑aberration correction for irregular‑cornea patients. Around the same time, the consolidation of EyePrint Prosthetics, Advanced Vision Technologies, and the WAVE Contact Lens System into WAVE Eye Care created a unified platform for fully customized scleral devices, streamlining the design‑to‑manufacturing workflow and expanding the clinical scope of prosthetic‑style lenses. Other recent moves include the introduction of new silicone‑hydrogel‑based scleral materials and enhanced digital‑fitting suites that reduce fitting time and improve predictability, all of which are expected to sustain the Scleral contact lenses market’s growth and push the Scleral contact lenses Price Trend gradually upward as higher‑specification designs become more widely adopted.

“Scleral contact lenses Production Data and Scleral contact lenses Production Trend, Scleral contact lenses Production Database and forecast”

• • • Scleral contact lenses production database for historical years, 12 years historical data
    • Scleral contact lenses production data and forecast for next 8 years